Get the Stockscreener App
5.87
1.73%
0.10
Pre-market:
5.92
0.05
+0.85%
Ardelyx Inc stock is traded at $5.87, with a volume of 2.01M.
It is up +1.73% in the last 24 hours and up +4.82% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$5.77
Open:
$5.81
24h Volume:
2.01M
Relative Volume:
0.59
Market Cap:
$1.43B
Revenue:
$386.15M
Net Income/Loss:
$-56.39M
P/E Ratio:
-25.52
EPS:
-0.23
Net Cash Flow:
$-55.19M
1W Performance:
-1.01%
1M Performance:
+4.82%
6M Performance:
+59.08%
1Y Performance:
+5.20%
1-Day Range:
$5.73
$5.92
1-Week Range:
$5.485
$6.00
52-Week Range:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.87 | 1.40B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
Why Ardelyx Inc. stock could see breakout soon2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Ardelyx (ARDX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Ardelyx Inc. stock maintain operating marginsPortfolio Value Report & AI Powered Market Trend Analysis - Newser
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News
Capital Fund Management S.A. Boosts Position in Ardelyx, Inc. $ARDX - MarketBeat
Can Ardelyx Inc. stock rebound after recent weakness2025 Performance Recap & Growth-Oriented Investment Plans - Newser
What catalysts could drive Ardelyx Inc. stock higherProduct Launch & Accurate Technical Buy Alerts - Newser
Ardelyx Inc. Reports Strong Q3 Earnings Growth - MSN
Can Ardelyx Inc. stock surprise with earnings upsideWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Will Ardelyx Inc. (41X) stock keep high P E multiplesInsider Selling & Expert-Curated Trade Recommendations - Newser
Is Ardelyx Inc. (41X) stock overpriced at current multiplesAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Is Ardelyx Inc a good long term investmentReal-Time Stock Alerts & Free Unmatched Market Performance - earlytimes.in
Fundamentals Check: Is Ardelyx Inc 41X stock overpriced at current multiples2025 Bull vs Bear & Weekly High Return Forecasts - BỘ NỘI VỤ
Aug Catalysts: How Ardelyx Inc 41X stock reacts to fiscal policiesQuarterly Risk Review & Verified High Yield Trade Plans - BỘ NỘI VỤ
Virtus Investment Advisers LLC Purchases 50,946 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Will Ardelyx Inc. stock deliver strong dividend growthJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Ardelyx Rides IBSRELA Demand To A Revenue Jump - Finimize
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript - Nasdaq
How Ardelyx Inc. (41X) stock reacts to weak economyQuarterly Portfolio Report & Stock Market Timing Techniques - BỘ NỘI VỤ
Ardelyx, Inc. Stock Soars 20.96%, Hits Intraday High of $6.73 - Markets Mojo
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth By Investing.com - Investing.com South Africa
Elizabeth Grammer Sells 5,995 Shares of Ardelyx (NASDAQ:ARDX) Stock - MarketBeat
[Form 4] ARDELYX, INC. Insider Trading Activity - Stock Titan
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Ardelyx Insider Sold Shares Worth $259,609, According to a Recent SEC Filing - marketscreener.com
Ardelyx insider Form 4 details 46,887-share RSU tax sale - Stock Titan
Officer Williams Surrenders 6,426 Of Ardelyx Inc [ARDX] - TradingView
Market Sentiment Around Loss-Making Ardelyx, Inc. (NASDAQ:ARDX) - 富途牛牛
Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth - Investing.com Nigeria
Ardelyx Inc Stock Analysis and ForecastEarnings Season Recap & Affordable Stock Picks - earlytimes.in
Ardelyx price target raised to $10 from $9 at Piper Sandler - MSN
How Ardelyx Inc. stock reacts to job market dataIndex Update & Proven Capital Preservation Methods - newser.com
Is Ardelyx Inc. (41X) stock ideal for retirement investorsMarket Activity Recap & Technical Analysis for Trade Confirmation - newser.com
Officer Williams Files To Sell 6,354 Of Ardelyx Inc [ARDX] - TradingView
Officer Reilly Files To Sell 10,845 Of Ardelyx Inc [ARDX] - TradingView
Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com
BTIG Maintains a Buy on Ardelyx, Inc (ARDX) - MSN
Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Ardelyx Inc. stock deliver shareholder valueQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Why institutional investors increase stakes in Ardelyx Inc. (41X) stockPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is Ardelyx Inc. forming a bottoming baseWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
What high frequency data says about Ardelyx Inc.Portfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):